Genetic testing for hemochromatosis: Attitudes and acceptability among young and older adults

被引:9
作者
Hicken, BL
Calhoun, DC
Tucker, DC
机构
[1] Univ Alabama, Dept Psychol, Birmingham, AL 35294 USA
[2] Univ Alabama, Dept Med, Birmingham, AL 35294 USA
来源
GENETIC TESTING | 2003年 / 7卷 / 03期
关键词
D O I
10.1089/109065703322537250
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Hemochromatosis is a genetic disorder of iron overload common in persons of northern European descent. We examined attitudes about testing for hemochromatosis in 118 young adults (YA) (19.7 years+/-1.9) and 50 older adults (OA) (58.5 years+/-13.7). Participants read about hemochromatosis and two related tests: transferrin saturation measurement (iron test) and HFE genotyping (HFE test). Interest in each test and attitudes about genetic testing were assessed. More than 80% of all participants were willing to undergo either test, if offered. A majority preferred the iron test because of the information it provides about current health. A majority of participants identified at least one benefit of genetic testing, with improved health through early detection/prevention being most common. YA were more likely to report disadvantages of genetic testing (p<0.001) and were more concerned about potential negative psychological effects (p<0.005). OA were more concerned about potential discrimination (p<0.0001). These findings suggest that young and older adults view genetic testing as beneficial and would accept HFE testing were it offered as part of a screening program.
引用
收藏
页码:235 / 239
页数:5
相关论文
共 6 条
[1]   Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer [J].
Bratt, O ;
Damber, JE ;
Emanuelsson, M ;
Kristoffersson, U ;
Lundgren, R ;
Olsson, H ;
Grönberg, H .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (02) :235-241
[2]   Hereditary hemochromatosis - Gene discovery and its implications for population-based screening [J].
Burke, W ;
Thomson, E ;
Khoury, MJ ;
McDonnell, SM ;
Press, N ;
Adams, PC ;
Barton, JC ;
Beutler, E ;
Brittenham, G ;
Buchanan, A ;
Clayton, EW ;
Cogswell, ME ;
Meslin, EM ;
Motulsky, AG ;
Powell, LW ;
Sigal, E ;
Wilfond, BS ;
Collins, FS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (02) :172-178
[3]   FAMILY SCREENING FOR GENETIC HEMOCHROMATOSIS - WHAT IS THE MOST EFFECTIVE METHOD OF CONTACT [J].
CLAYTON, C ;
HALL, P ;
MACKINNON, M .
MEDICAL JOURNAL OF AUSTRALIA, 1993, 159 (09) :614-615
[4]   ATTITUDES ABOUT GENETIC TESTING FOR BREAST-OVARIAN CANCER SUSCEPTIBILITY [J].
LERMAN, C ;
DALY, M ;
MASNY, A ;
BALSHEM, A .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (04) :843-850
[5]   Screening for hemochromatosis in primary care settings [J].
McDonnell, SM ;
Phatak, PD ;
Felitti, V ;
Hover, A ;
McLaren, GD .
ANNALS OF INTERNAL MEDICINE, 1998, 129 (11) :962-970
[6]   Haemochromatosis: diagnosis and management after the cloning of the HFE gene [J].
Powell, LW ;
Bassett, ML .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1998, 28 (02) :159-163